CureVac NV Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

CureVac NV Stock Summary

CureVac NV competes with Merit Medical, SmartStop Self, Cadence Design, Microbot Medical, and Asure Software. CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid . The company was founded in 2000 and is headquartered in Tbingen, Germany. Curevac NV operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 764 people.

CureVac NV Key Financial Ratios

CureVac NV Key Balance Sheet Accounts

CureVac NV Key Income Statement Accounts

CureVac NV Key Cash Accounts

CureVac Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining CureVac NV's current stock value. Our valuation model uses many indicators to compare CureVac NV value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CureVac NV competition to find correlations between indicators driving CureVac NV's intrinsic value. More Info.CureVac NV is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers . At present, CureVac NV's Return On Equity is projected to increase slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CureVac NV's earnings, one of the primary drivers of an investment's value.

CureVac NV Systematic Risk

Today, most investors in CureVac NV Stock are looking for potential investment opportunities by analyzing not only static indicators but also various CureVac NV's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of CureVac NV growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of CureVac NV help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CureVac NV. We use our internally-developed statistical techniques to arrive at the intrinsic value of CureVac NV based on widely used predictive technical indicators. In general, we focus on analyzing CureVac Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CureVac NV's daily price indicators and compare them against related drivers.

When running CureVac NV's price analysis, check to measure CureVac NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CureVac NV is operating at the current time. Most of CureVac NV's value examination focuses on studying past and present price action to predict the probability of CureVac NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CureVac NV's price. Additionally, you may evaluate how the addition of CureVac NV to your portfolios can decrease your overall portfolio volatility.